Nutrición

Nutrients, Vol. 17, Pages 3353: Metabolic Disruption in Osteoporotic Sheep: Evaluating Vitamin D Deficiency and Cortisone Effects via Biochemical Markers Nutrients doi: 10.3390/nu17213353 Authors: Gero Knapp Judith Langenstein Natali Bauer Sabine Stötzel Christian Heiss Vahid Jahed Muhammad Alzweiri Christoph Biehl Thaqif El Khassawna Background/Objectives: We evaluated serum and urinary biomarkers of bone and energy metabolism […]

Publication date: February 2026 Source: Nutrition, Volume 142 Author(s): Qian You, Linhua Zhou, Ya Ma, Jiankui Guo, Yi Wang, Lei Shi, Yanru Deng, Zhiyong Rao, Xuemei Li ​Publication date: February 2026Source: Nutrition, Volume 142Author(s): Qian You, Linhua Zhou, Ya Ma, Jiankui Guo, Yi Wang, Lei Shi, Yanru Deng, Zhiyong Rao, Xuemei Li Read More

Nutrients, Vol. 17, Pages 3352: Body Composition Analysis in Postoperative Breast Cancer Patients Undergoing Chemotherapy and Its Association with Physical Activity and Quality of Life: A Longitudinal Pilot Study Nutrients doi: 10.3390/nu17213352 Authors: Joanna Grupińska Marika Wlazło Mateusz Grajek Magdalena Budzyń Ewa Malchrowicz-Mośko Tomasz Jurys Background/Objectives: Breast cancer survivors often experience adverse body composition changes

Nutrients, Vol. 17, Pages 3351: Nutritional Practices and Knowledge of Patients with Phenylketonuria Nutrients doi: 10.3390/nu17213351 Authors: Eirini Kaloteraki Eleni C. Pardali Dimitrios Poulimeneas Varvara Mylona Eleni Fotiadou Kyriaki Papa Aristea Gioxari Martha Spilioti Dimitrios P. Bogdanos Maria G. Grammatikopoulou Background/Objectives: Phenylketonuria (PKU) is an inborn error of metabolism (IEM) that requires a specialized medical

Nutrients, Vol. 17, Pages 3350: The Gut Microbiome and Its Impact on Mood and Decision-Making: A Mechanistic and Therapeutic Review Nutrients doi: 10.3390/nu17213350 Authors: Pierluigi Diotaiuti Francesco Misiti Giulio Marotta Lavinia Falese Giovanna Elisa Calabrò Stefania Mancone Background/Objectives: The gut microbiome is increasingly recognized as a key modulator of central nervous system function through the

Nutrients, Vol. 17, Pages 3346: Protein and Macronutrient Metabolism in Liver Cirrhosis: About Sarcopenia Nutrients doi: 10.3390/nu17213346 Authors: Seul Ki Han Soon Koo Baik Moon Young Kim Malnutrition, sarcopenia, and frailty are highly prevalent in patients with chronic liver disease and are closely associated with poor clinical outcomes. This review highlights the complex interplay between

Nutrients, Vol. 17, Pages 3347: Assessing Appetite–Validation of a Picture-Based Appetite Assessment Tool for Children Aged 6–9 Years—A Pilot Study Nutrients doi: 10.3390/nu17213347 Authors: Sigal Eilat-Adar Yoav Zeevi Efrat Shaked Yael Rabih Sima Zach Background: Recognizing and balancing internal and external appetite cues is critical for controlling food intake in young children. The main aim

Nutrients, Vol. 17, Pages 3349: Dietary Interventions for Adults with Type 1 Diabetes: Clinical Outcomes, Guideline Alignment, and Research Gaps—A Scoping Review Nutrients doi: 10.3390/nu17213349 Authors: Beata Małgorzata Sperkowska Agnieszka Chrustek Anna Gryn-Rynko Anna Proszowska Background/Objectives: Medical nutrition therapy (MNT) is a crucial component of type 1 diabetes (T1D) management; however, the effectiveness of specific

Nutrients, Vol. 17, Pages 3348: CYP24A1 in Small Intestinal Vitamin D Metabolism and Clinical Implications Nutrients doi: 10.3390/nu17213348 Authors: Agnieszka Nowacka Maciej Śniegocki Dominika Bożiłow Ewa A. Ziółkowska CYP24A1, a mitochondrial cytochrome P450 enzyme, plays a critical role in the catabolism of active vitamin D metabolites and is a key regulator of local vitamin D

Nutrients, Vol. 17, Pages 3344: Nutritional Approaches in Neurodegenerative Disorders: A Mini Scoping Review with Emphasis on SPG11-Related Conditions Nutrients doi: 10.3390/nu17213344 Authors: Paulo Renato Ribeiro Carmen Ferreira Carlos Antunes Gonçalo Dias Maria João Lima Raquel Guiné Edite Teixeira-Lemos Background: Neurodegenerative diseases, including spastic paraplegia type 11 (SPG11), are complex disorders characterized by progressive neurological